Back
Cadrenal Therapeutics Vs. Viking Therapeutics Industry Stock Comparison
Buy
84
CVKD
Cadrenal Therapeutics
Last Price:
14.50
Seasonality Move:
-23.97%
Buy
58
VKTX
Viking Therapeutics
Last Price:
61.63
Seasonality Move:
36.82%
Buy
84
Cadrenal Therapeutics (CVKD)
is a Buy
Is Cadrenal Therapeutics a Buy, Sell or Hold?
- The current Cadrenal Therapeutics [CVKD] share price is $14.50. The Score for CVKD is 84, which is 68% above its historic median score of 50, and infers lower risk than normal.
- CVKD is currently trading in the 80-90% percentile range relative to its historical Stock Score levels.
- This Score is currently showing an extreme reading that indicates risk levels may be considerably lower than normal.
Buy
58
Viking Therapeutics (VKTX)
is a Buy
Is Viking Therapeutics a Buy, Sell or Hold?
- The current Viking Therapeutics [VKTX] share price is $61.63. The Score for VKTX is 58, which is 16% above its historic median score of 50, and infers lower risk than normal.
- VKTX is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
CVKD Stock Price Chart
What is Cadrenal Therapeutics's stock price today?
-
The Cadrenal Therapeutics share price today is $14.50
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and CVKD is experiencing selling pressure, which indicates risk of future bearish movement.
VKTX Stock Price Chart
What is Viking Therapeutics's stock price today?
-
The Viking Therapeutics share price today is $61.63
The current trend is moderately bearish and VKTX is experiencing selling pressure, which indicates risk of future bearish movement.
CVKD Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 1.65 | Buy |
| Relative Strength Index (14 RSI): | 73.12 | Buy |
| Chaikin Money Flow: | -36766 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (7.36 - 12.16) | Buy |
| Bollinger Bands (100): | (5.76 - 9.34) | Buy |
VKTX Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 1.12 | Buy |
| Relative Strength Index (14 RSI): | 49.26 | Sell |
| Chaikin Money Flow: | -1176939 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (57.9 - 66.32) | Sell |
| Bollinger Bands (100): | (52.14 - 66.8) | Buy |
CVKD Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 12.51 | Buy |
| 20-day SMA: | 10.31 | Buy |
| 50-day SMA: | 8.23 | Buy |
| 200-day SMA: | 9.1 | Buy |
| 8-day EMA: | 12.76 | Buy |
| 20-day EMA: | 10.93 | Buy |
| 50-day EMA: | 9.1 | Buy |
| 200-day EMA: | 9.64 | Buy |
VKTX Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 64.66 | Sell |
| 20-day SMA: | 61.87 | Sell |
| 50-day SMA: | 59.76 | Buy |
| 200-day SMA: | 53.91 | Buy |
| 8-day EMA: | 63.35 | Sell |
| 20-day EMA: | 62.66 | Sell |
| 50-day EMA: | 60.77 | Buy |
| 200-day EMA: | 52.02 | Buy |
Cadrenal Therapeutics Earnings Growth & CVKD Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.45 per share, an increase next quarter of $0.60 per share, an increase this year of $2.18 per share, and an increase next year of $1.80 per share.
Viking Therapeutics Earnings Growth & VKTX Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.02 per share, a decrease next quarter of $0.13 per share, a decrease this year of $0.05 per share, and a decrease next year of $0.55 per share.
Cadrenal Therapeutics Technical Analysis
| Sep 16 | Sep 17 | Sep 18 | Sep 19 | Sep 20 | Sep 23 | Sep 24 | Sep 25 | Sep 26 | Sep 27 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep | ||||||||||
| 16 | 17 | 18 | 19 | 20 | 23 | 24 | 25 | 26 | 27 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Viking Therapeutics Technical Analysis
| Sep 16 | Sep 17 | Sep 18 | Sep 19 | Sep 20 | Sep 23 | Sep 24 | Sep 25 | Sep 26 | Sep 27 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep | ||||||||||
| 16 | 17 | 18 | 19 | 20 | 23 | 24 | 25 | 26 | 27 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||